Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Semaglutide is a GLP-1 agonist, a class of medication that mimics the hormone glucagon-like peptide-1
Although not explicitly marketed as a weight loss medication, studies funded by Novo Nordisk, the manufacturer of Ozempic, suggest that individuals taking semaglutidethe active ingredientmay experience weight loss
In this case, they stimulate aryl hydrocarbon receptors, which encourage your body to produce more glucagon, the precursor to GLP-1
Change in Body Weight (%) from Baseline to Week 72 (Study 8) with WEGOVY 7.2 mg Injection Observed data from in-trial period including imputed data for missing observations (RD-MI)
Ibrahim WW, Skalicka-Woniak K, Budzyska B, El Sayed NS (2023) NLRP3 inflammasome inhibition and M1-to-M2 microglial polarization shifting via scoparone-inhibited TLR4 axis in ovariectomy/D-galactose Alzheimers disease rat model
Improving insulin sensitivity helps prevent the storage of excess fat and ensures that the body is better able to process and use glucose for energy rather than storing it as fat
